IRIS
COMOLLI, GIUDITTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.180
AS - Asia 937
EU - Europa 720
SA - Sud America 127
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.015
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.140
CN - Cina 294
SG - Singapore 255
IT - Italia 182
VN - Vietnam 145
HK - Hong Kong 115
RU - Federazione Russa 112
IE - Irlanda 105
BR - Brasile 87
DE - Germania 85
FI - Finlandia 60
FR - Francia 41
GB - Regno Unito 35
ZA - Sudafrica 34
IN - India 26
SE - Svezia 18
IQ - Iraq 17
PL - Polonia 17
MX - Messico 16
CA - Canada 15
BD - Bangladesh 12
JP - Giappone 12
BE - Belgio 11
VE - Venezuela 11
ES - Italia 10
UA - Ucraina 10
PH - Filippine 9
ID - Indonesia 8
NL - Olanda 8
AR - Argentina 7
TR - Turchia 7
AT - Austria 6
EC - Ecuador 5
CL - Cile 4
CO - Colombia 4
CZ - Repubblica Ceca 4
LT - Lituania 4
MA - Marocco 4
PY - Paraguay 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
BH - Bahrain 3
AL - Albania 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
JM - Giamaica 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NP - Nepal 2
PE - Perù 2
PK - Pakistan 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
MN - Mongolia 1
MU - Mauritius 1
MY - Malesia 1
MZ - Mozambico 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TM - Turkmenistan 1
Totale 3.015
Salva come PNG Salva come JPEG
Città #
Dallas 177
Singapore 156
San Jose 149
Ashburn 132
Hong Kong 114
Dublin 101
Beijing 83
Chandler 77
New York 60
Ho Chi Minh City 48
Munich 48
Milan 44
Los Angeles 38
Helsinki 36
Pavia 36
Boardman 33
Hanoi 29
Johannesburg 29
Lauterbourg 28
Ann Arbor 26
Shanghai 24
Council Bluffs 19
Moscow 18
Nanjing 18
Turku 18
Redondo Beach 17
Princeton 16
Jacksonville 14
Orem 14
Santa Clara 14
Lawrence 13
Wilmington 13
Buffalo 12
Warsaw 12
Frankfurt am Main 11
Rome 11
Seattle 11
Tokyo 11
Brooklyn 10
Medford 10
Poplar 10
Biên Hòa 8
Brussels 8
Chennai 8
Denver 8
Shenyang 8
São Paulo 8
The Dalles 8
Toronto 8
Da Nang 7
Hebei 7
Mexico City 7
Nanchang 7
Stockholm 7
Baghdad 6
Amsterdam 5
Düsseldorf 5
London 5
San Francisco 5
Columbus 4
Corsico 4
Falls Church 4
Hangzhou 4
Jinan 4
Piscataway 4
Pune 4
Vũng Tàu 4
Atlanta 3
Belo Horizonte 3
Boston 3
Cascina 3
Changsha 3
Charlotte 3
Guangzhou 3
Ha Long 3
Haiphong 3
Hamad Town 3
Houston 3
Hải Dương 3
Jiaxing 3
Montreal 3
Mumbai 3
Nha Trang 3
Tashkent 3
Tianjin 3
Vigevano 3
Washington 3
Amman 2
Annapolis 2
Bereguardo 2
Bogotá 2
Brescia 2
Buccinasco 2
Bulungan 2
Bắc Giang 2
Bắc Ninh 2
Bến Tre 2
Cairo 2
Cao Lanh 2
Caracas 2
Totale 1.983
Salva come PNG Salva come JPEG
Nome #
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation 161
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 157
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 149
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 139
Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. 132
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 130
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 129
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 128
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 118
Occult HIV infection in a large sample of health-care users in Lombardy, Italy in 2014-2015: Implications for control strategies 110
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 109
Human Cytomegalovirus-Specific Memory CD4+T-Cell Response and Its Correlation with Virus Transmission to the Fetus in Pregnant Women with Primary Infection 105
Dengue Virus-Specific Humoral and T Cellular Immune Response in Italian Residents and Travelers Returning from Endemic Areas 103
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers 101
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 98
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy 94
Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation. 94
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 93
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 90
Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay 88
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 85
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay 83
The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy 82
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 82
Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis 79
Performance of new pp65-IGRA for the quantification of HCMV-specific CD4+ T-cell response in healthy subjects and in solid organ transplant recipients 76
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 69
Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up 69
Memory T cells specific for HBV enumerated by a peptide-based cultured enzyme-linked immunospot assay in healthy HBV-vaccinated subjects 49
Different Antigen-Specific CD4+ and CD8+ T-Cell Response against HCMV Proteins in Pregnant Women with Primary Infection and in Control Subjects with Remote Infection 46
Totale 3.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202294 3 2 2 2 4 4 7 8 1 12 9 40
2022/2023284 17 27 2 18 12 19 0 7 120 2 55 5
2023/2024258 24 34 11 9 13 82 26 17 1 8 17 16
2024/2025620 17 34 9 45 13 47 32 22 152 39 74 136
2025/20261.614 104 113 209 185 185 83 317 91 134 94 63 36
Totale 3.048